New posts

Reply to thread

Message

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company’s HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor; and CF-33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. Imugene Limited was incorporated in 1986 and is headquartered in Sydney, Australia.

Has jumped out of the box!!!" I'm hearing on the news all this activity about cures and treatments for cancer a" breakthrough". IMU may be the next big thing!.

<blockquote data-quote="Stockbailx" data-source="post: 1120681" data-attributes="member: 85616">Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company’s HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor; and CF-33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. Imugene Limited was incorporated in 1986 and is headquartered in Sydney, Australia.<img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="smilie smilie--sprite smilie--sprite21" alt=":banghead:" title="Bang Head&nbsp; &nbsp; :banghead:" loading="lazy" data-shortname=":banghead:" />Has jumped out of the box!!!&quot; I&#039;m hearing on the news all this activity about cures and treatments for cancer a&quot; breakthrough&quot;. IMU may be the next big thing!.<img src="https://www.aussiestockforums.com/styles/default/xenforo/smilies/wheniwasaboy.gif"&nbsp; class="smilie" loading="lazy" alt=":wheniwasaboy:" title="When I Was a Boy&nbsp; &nbsp; :wheniwasaboy:" data-shortname=":wheniwasaboy:" /><img src="https://www.aussiestockforums.com/styles/default/xenforo/smilies/twocents.gif"&nbsp; class="smilie" loading="lazy" alt=":2twocents" title="Two Cents&nbsp; &nbsp; :2twocents" data-shortname=":2twocents" /></blockquote>

[QUOTE="Stockbailx, post: 1120681, member: 85616"] Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company’s HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor; and CF-33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. Imugene Limited was incorporated in 1986 and is headquartered in Sydney, Australia.:banghead: Has jumped out of the box!!!" I'm hearing on the news all this activity about cures and treatments for cancer a" breakthrough". [B][I] IMU may be the next big thing![/I][/B][I].[/I] :wheniwasaboy::2twocents [/QUOTE]

Verification